Ted Halmos

1.4k total citations
15 papers, 747 citations indexed

About

Ted Halmos is a scholar working on Hepatology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases. According to data from OpenAlex, Ted Halmos has authored 15 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hepatology, 8 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Infectious Diseases. Recurrent topics in Ted Halmos's work include Hepatitis C virus research (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and HIV/AIDS drug development and treatment (6 papers). Ted Halmos is often cited by papers focused on Hepatitis C virus research (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and HIV/AIDS drug development and treatment (6 papers). Ted Halmos collaborates with scholars based in Canada, Egypt and Germany. Ted Halmos's co-authors include Murray D. Bailey, Montse Llinàs‐Brunet, Martin Poirier, Vida Gorys, Élise Ghiro, Daniel Lamarre, Diane Thibeault, Roger Maurice, Marc‐André Poupart and Jean Rancourt and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Organic Letters.

In The Last Decade

Ted Halmos

15 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ted Halmos Canada	12	451	255	252	215	202	15	747
Gulrez Fazal Canada	13	371 0.8×	207 0.8×	267 1.1×	275 1.3×	256 1.3×	16	810
Sylvie Goulet Canada	16	510 1.1×	256 1.0×	351 1.4×	290 1.3×	292 1.4×	20	939
Vida Gorys Canada	14	347 0.8×	296 1.2×	230 0.9×	139 0.6×	419 2.1×	21	827
Marc‐André Poupart Canada	18	550 1.2×	520 2.0×	346 1.4×	303 1.4×	391 1.9×	29	1.3k
Élise Ghiro Canada	11	251 0.6×	210 0.8×	166 0.7×	120 0.6×	258 1.3×	15	582
Murray D. Bailey Canada	15	465 1.0×	321 1.3×	273 1.1×	230 1.1×	609 3.0×	25	1.2k
Stefania Colarusso Italy	12	295 0.7×	184 0.7×	174 0.7×	144 0.7×	218 1.1×	16	619
Jean Gauthier Canada	14	245 0.5×	204 0.8×	194 0.8×	206 1.0×	194 1.0×	31	728
Van N. Nguyen United States	12	639 1.4×	219 0.9×	260 1.0×	498 2.3×	303 1.5×	14	1.1k
James Gillard Canada	19	330 0.7×	314 1.2×	273 1.1×	177 0.8×	469 2.3×	30	975

Countries citing papers authored by Ted Halmos

Since Specialization

Citations

This map shows the geographic impact of Ted Halmos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ted Halmos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ted Halmos more than expected).

Fields of papers citing papers by Ted Halmos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ted Halmos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ted Halmos. The network helps show where Ted Halmos may publish in the future.

Co-authorship network of co-authors of Ted Halmos

This figure shows the co-authorship network connecting the top 25 collaborators of Ted Halmos. A scholar is included among the top collaborators of Ted Halmos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ted Halmos. Ted Halmos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Fader, Lee D., Rebekah Carson, Sébastien Morin, et al.. (2014). Minimizing the Contribution of Enterohepatic Recirculation to Clearance in Rat for the NCINI Class of Inhibitors of HIV. ACS Medicinal Chemistry Letters. 5(6). 711–716. 14 indexed citations

Bilodeau, François, Murray D. Bailey, Josée Bordeleau, et al.. (2013). Synthesis and optimization of a novel series of HCV NS3 protease inhibitors: 4-Arylproline analogs. Bioorganic & Medicinal Chemistry Letters. 23(14). 4267–4271. 4 indexed citations

Llinàs‐Brunet, Montse, Murray D. Bailey, Nathalie Goudreau, et al.. (2010). Discovery of a Potent and Selective Noncovalent Linear Inhibitor of the Hepatitis C Virus NS3 Protease (BI 201335). Journal of Medicinal Chemistry. 53(17). 6466–6476. 57 indexed citations

Kawai, Stephen H., Murray D. Bailey, Ted Halmos, et al.. (2008). The Use of Chemical Double‐Mutant Cycles in Biomolecular Recognition Studies: Application to HCV NS3 Protease Inhibitors. ChemMedChem. 3(11). 1654–1657. 13 indexed citations

Bailey, Murray D., Ted Halmos, Nathalie Goudreau, Ewen Lescop, & Montse Llinàs‐Brunet. (2004). Novel Azapeptide Inhibitors of Hepatitis C Virus Serine Protease. Journal of Medicinal Chemistry. 47(15). 3788–3799. 28 indexed citations

Faucher, Anne‐Marie, Murray D. Bailey, Pierre L. Beaulieu, et al.. (2004). Synthesis of BILN 2061, an HCV NS3 Protease Inhibitor with Proven Antiviral Effect in Humans. Organic Letters. 6(17). 2901–2904. 74 indexed citations

Llinàs‐Brunet, Montse, Murray D. Bailey, Gordon T. Bolger, et al.. (2004). Structure−Activity Study on a Novel Series of Macrocyclic Inhibitors of the Hepatitis C Virus NS3 Protease Leading to the Discovery of BILN 2061. Journal of Medicinal Chemistry. 47(7). 1605–1608. 105 indexed citations

Llinàs‐Brunet, Montse, Murray D. Bailey, Élise Ghiro, et al.. (2004). A Systematic Approach to the Optimization of Substrate-Based Inhibitors of the Hepatitis C Virus NS3 Protease: Discovery of Potent and Specific Tripeptide Inhibitors. Journal of Medicinal Chemistry. 47(26). 6584–6594. 94 indexed citations

Pause, Arnim, George Kukolj, Murray D. Bailey, et al.. (2003). An NS3 Serine Protease Inhibitor Abrogates Replication of Subgenomic Hepatitis C Virus RNA. Journal of Biological Chemistry. 278(22). 20374–20380. 74 indexed citations

10.

Llinàs‐Brunet, Montse, Murray D. Bailey, Gulrez Fazal, et al.. (2000). Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(20). 2267–2270. 78 indexed citations

11.

Simoneau, Bruno, Pierre Lavallée, Paul C. Anderson, et al.. (1999). Discovery of non-peptidic P2–P3 butanediamide renin inhibitors with high oral efficacy. Bioorganic & Medicinal Chemistry. 7(3). 489–508. 27 indexed citations

12.

Bailey, Murray D., et al.. (1999). Chemo-enzymatic synthesis of chiral 2-substituted succinic acid derivatives. Tetrahedron Asymmetry. 10(17). 3285–3295. 5 indexed citations

13.

Llinàs‐Brunet, Montse, Murray D. Bailey, Gulrez Fazal, et al.. (1998). Peptide-based inhibitors of the hepatitis C virus serine protease. Bioorganic & Medicinal Chemistry Letters. 8(13). 1713–1718. 113 indexed citations

14.

Llinàs‐Brunet, Montse, Murray D. Bailey, Robert Déziel, et al.. (1998). Studies on the C-terminal of hexapeptide inhibitors of the hepatitis C virus serine protease. Bioorganic & Medicinal Chemistry Letters. 8(19). 2719–2724. 60 indexed citations

15.

Halmos, Ted, et al.. (1958). [Clinically diagnosed cardiac metastasis causing ventricular tachycardia].. PubMed. 99(6). 208–12. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact